These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3514345)

  • 61. Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release.
    Salminen EK; Salminen SJ; Porkka L; Kwasowski P; Marks V; Koivistoinen PE
    Am J Clin Nutr; 1989 Jun; 49(6):1228-32. PubMed ID: 2658536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of gastric inhibitory polypeptide and arginine with glucose in the perfused pancreas of rats treated with triiodothyronine.
    Mueller MK; Pederson RA; Brown JC
    Can J Physiol Pharmacol; 1982 Mar; 60(3):297-301. PubMed ID: 7042057
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of acetylcholine-stimulated insulin release by glucose and gastric inhibitory polypeptide.
    Verchere CB; Kwok YN; Brown JC
    Pharmacology; 1991; 42(5):273-82. PubMed ID: 1678891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
    Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
    Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent.
    Pederson RA; Campos RV; Buchan AM; Chisholm CB; Russell JC; Brown JC
    Int J Obes; 1991 Jul; 15(7):461-70. PubMed ID: 1894423
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide.
    Guo YS; Singh P; Draviam E; Greeley GH; Thompson JC
    Gastroenterology; 1989 Mar; 96(3):690-4. PubMed ID: 2644149
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
    Holst JJ
    BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radioimmunoassay of gastric inhibitory polypeptide (GIP) and the effect of intraduodenal acidification on glucose-stimulated and unstimulated GIP release in humans.
    Flaten O
    Scand J Gastroenterol; 1981; 16(4):545-54. PubMed ID: 7034154
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
    Meier JJ; Holst JJ; Schmidt WE; Nauck MA
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1420-6. PubMed ID: 11820780
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fasting portal vein plasma levels of gastric inhibitory polypeptide (GIP) and extractable fasting GIP in the duodenal wall in rats treated with methylprednisolone or alloxan compared with normal controls.
    Schulz TB; Jorde R; Burhol PG
    Scand J Gastroenterol; 1982 Jun; 17(4):487-90. PubMed ID: 6753106
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study.
    Møller CL; Vistisen D; Færch K; Johansen NB; Witte DR; Jonsson A; Pedersen O; Hansen T; Lauritzen T; Jørgensen ME; Torekov SS; Holst JJ
    J Clin Endocrinol Metab; 2016 Feb; 101(2):485-93. PubMed ID: 26505824
    [TBL] [Abstract][Full Text] [Related]  

  • 77. GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release.
    Ahrén B; Håkanson R; Lundquist I; Sjölund K; Sundler F
    Acta Physiol Scand; 1981 Jul; 112(3):233-42. PubMed ID: 7027739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
    Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
    Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T; Koga T; Sasaki K; Hara H
    Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice.
    Shimotoyodome A; Suzuki J; Fukuoka D; Tokimitsu I; Hase T
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E652-62. PubMed ID: 20009028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.